Development of a bidirectional caspase-3 expression system for the induction of apoptosis

Cancer Biology and Therapy

Volumn 7, Issue 6, 2008, Pages 945-954

  White, Martyn K ^a   Amini, Shohreh ^a,b   Khalili, Kamel ^a,c   Darbinian, Nune ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Temple University   (United States)

^c NONE   (United States)

Author keywords

Apoptosis; Cancer therapy; Caspases; Protein transduction; Tat uptake

Indexed keywords

CASPASE 3; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; PROTEIN SUBUNIT; TRANSACTIVATOR PROTEIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ACTIVE TRANSPORT; CELL FRACTIONATION; CELL SURVIVAL; ENZYME ACTIVATION; FLUORESCENCE MICROSCOPY; GENE EXPRESSION REGULATION; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

ACTIVE TRANSPORT, CELL NUCLEUS; APOPTOSIS; BASE SEQUENCE; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GREEN FLUORESCENT PROTEINS; HUMANS; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; SUBCELLULAR FRACTIONS;

EID: 56149126835     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.7.6.5969     Document Type: Article

References (26)

1. Bremer E, van Dam G, Kroesen BJ, de Leij L, Helfrich W. Targeted induction of apoptosis for cancer therapy: current progress and prospects. Trends Mol Med 2006; 12:382-93.
2. Russo A, Terrasi M, Agnese V, Santini D, Bazan V. Apoptosis: a relevant tool for anticancer therapy. Ann Oncol 2006; 17:115-23.
3. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell 2004; 116:205-19.
4. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407:770-6.
5. Li P, Nijhawan D, Wang X. Mitochondrial activation of apoptosis. Cell 2004; 116:57-9.
6. White MK, McCubrey JA. Suppression of apoptosis: role in cell growth and neoplasia. Leukemia 2001; 15:1011-21.
7. Yuan J, Horvitz HR. A first insight into the molecular mechanisms of apoptosis. Cell 2004; 116:53-6.
8. Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326:1-6.
9. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 1993; 75:641-52.
10. Fraser A, Evan G. A license to kill. Cell 1996; 85:781-4.
11. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res 1993; 53:3976-85.
12. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391:43-50.
13. Song Q, Lees-Miller SP, Kumar S, Zhang N, Chan DW, Smith GCM, Jackson SP, Alnemri ES, Litwack G, Khanna KK, Lavin MF. DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J 1996; 15:3238-46.
14. Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 1994; 269:30761-4.
15. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376:37-43.
16. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995; 81:801-9.
17. Bleackley RC, Heibein JA. Enzymatic control of apoptosis. Nat Prod Rep 2001; 18:431-40.
18. Coloma MJ, Hastings A, Wims LA, Morrison SL. Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction. J Immunol Methods 1992; 152:89-104.
19. Ruben S, Perkins A, Purcell R, Joung K, Sia R, Burghoff R, Haseltine WA, Rosen CA. Structural and functional characterization of human immunodeficiency virus Tat protein. J Virol 1989; 63:1-8.
20. Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 1997; 272:16010-7.
21. Darbinian N, Popov Y, Khalili K, Amini S. Creation of a bi-directional protein transduction system for suppression of HIV-1 expression by p27SJ. Antiviral Res 2008; in press.
22. Darbinian-Sarkissian N, Darbinyan A, Otte J, Radhakrishnan S, Sawaya BE, Arzumanyan A, Chipitsyna G, Popov Y, Rappaport J, Amini S, Khalili K. p27(SJ), a novel protein in St. John's Wort, that suppresses expression of HIV-1 genome. Gene Ther 2006; 13:288-95.
23. Kamada S, Kikkawa U, Tsujimoto Y, Hunter T. Nuclear translocation of caspase-3 is dependent on its proteolytic activation and recognition of a substrate-like protein(s). J Biol Chem 2005; 280:857-60.
24. Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973; 52:456-67.
25. Takakura M, Kyo S, Kanaya T, Hirano H, Takeda J, Yutsudo M, Inoue M. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res 1999; 59:551-7.
26. Li F, Altieri DC. Transcriptional analysis of human survivin gene expression. Biochem J 1999; 344:305-11.